- Studies indicate a lack of awareness among health care professionals
of pain perception, assessment, and management in neonates
- AAP recommendations support the use of: 1) validated measures and assessment tools to evaluate and reduce
the stress and pain experienced by neonates, 2) appropriate environmental,
nonpharmacological (behavioral), and pharmacological interventions
to prevent, reduce, or eliminate the stress and pain of neonates and
3) agents with known pharmacokinetic and pharmacodynamic properties
and demonstrated efficacy in neonates.3
- Infants who have experienced pain during the neonatal period have
been shown to respond differently to subsequent painful events. The
use of appropriate analgesia ameliorates this outcome.
M, et al. Pain reduction at venipuncture in newborns: oral glucose compared
with local anesthetic cream. Pediatrics 2002; 110:1053-1057.
B, Johnston C, Petryshen P, Taddio A. Premature Infant Pain Profile:
development and initial validation. Clin J Pain. 1996;12:13-22.
Academy of Pediatrics. Policy Statement: Evaluation and management of
pain and stress in the neonate. Pediatrics 2000; 105:454-461.